Target intelligence / Profile preview

Enterotoxigenic Escherichia coli antigens (ETEC antigens)

Target
ETEC antigens
Molecular classification
Bacterial toxin, Bacterial surface protein, Adhesin, Enterotoxin
01

Overview

Enterotoxigenic Escherichia coli (ETEC) antigens are the primary virulence factors of ETEC, the leading cause of bacterial diarrhea worldwide, particularly in children and travelers to endemic areas (Qadri et al., 2005, Clinical Microbiology Reviews). These antigens include heat-labile enterotoxin (LT), heat-stable enterotoxin (ST), and a variety of colonization factors (CFs), which are surface-expressed fimbriae or pili (Fleckenstein et al., 2010, Nature Reviews Microbiology). LT is an AB5-type toxin that increases intracellular cAMP levels, while ST is a small peptide that activates guanylate cyclase C to increase cGMP, both leading to chloride secretion and water loss in the intestine (Walker et al., 2015, Vaccine). Colonization factors facilitate the initial attachment of the bacteria to the intestinal mucosa, a prerequisite for colonization and subsequent toxin delivery. These antigens serve as the target for both prophylactic vaccines, such as the whole-cell inactivated ETVAX, and passive immunotherapies like hyperimmune bovine colostrum. Because the cholera toxin B-subunit is highly homologous to the ETEC LT B-subunit, certain oral cholera vaccines provide cross-protective immunity against LT-producing ETEC strains (Clemens et al., 2004, The Lancet).

Other names
ETEC toxinsColonization factorsHeat-labile enterotoxinHeat-stable enterotoxinCFAColonization factor antigens
02

Mechanism of action

Neutralization of LT and ST enterotoxins to prevent fluid secretion and blockade of colonization factors to inhibit bacterial adherence to the intestinal epithelium.

03

Biological functions

Bacterial adhesionIntestinal secretion inductionPathogenesisHost-pathogen interactionSignal transduction
04

Disease associations

Traveler's diarrheaChildhood diarrheaInfection
05

Safety considerations

Vaccine reactogenicityInduction of mucosal toleranceStrain-specific immunity variabilityPotential for cross-reactivity with endogenous proteins
06

Interacting drugs

Dukoral

5 more in the full profile.

07

Biomarkers

Stool LT/ST enterotoxin detection (ELISA)LT/ST virulence genes (PCR)Anti-CFA IgA antibody titersAnti-LTB antibody levels

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli antigens (ETEC antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli antigens (ETEC antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call